Zobrazeno 1 - 7
of 7
pro vyhledávání: '"François-Xavier Chalet"'
Autor:
François-Xavier Chalet, Orestis Briasoulis, Eric J. Manalastas, Darren A. Talbot, Juliette C. Thompson, R. Loch Macdonald
Publikováno v:
Neurology and Therapy, Vol 12, Iss 2, Pp 371-390 (2023)
Plain Language Summary Aneurysmal subarachnoid hemorrhage is a medical emergency in which an aneurysm, a weakened outpouching of a cerebral blood vessel, ruptures causing bleeding in the subarachnoid space. Components from the bleeding can trigger a
Externí odkaz:
https://doaj.org/article/abd777411091478a8016a79471a2e237
Autor:
François-Xavier Chalet, Teodora Bujaroska, Evi Germeni, Nizar Ghandri, Emilio T. Maddalena, Kushal Modi, Abisola Olopoenia, Jeffrey Thompson, Matteo Togninalli, Andrew H. Briggs
Publikováno v:
PharmacoEconomics - Open. 7:149-161
Autor:
François-Xavier Chalet, Paul Saskin, Ajay Ahuja, Jeffrey Thompson, Abisola Olopoenia, Kushal Modi, Charles M. Morin, Emerson M. Wickwire
Publikováno v:
Journal of Clinical Medicine; Volume 12; Issue 6; Pages: 2438
Little is known about the associations between insomnia severity, insomnia symptoms, and key health outcomes. Using 2020 United States National Health and Wellness Survey (NHWS) data, we conducted a retrospective, cross-sectional analysis to determin
Publikováno v:
Médecine du Sommeil. 20:26-27
Autor:
François-Xavier, Chalet, Orestis, Briasoulis, Eric J, Manalastas, Darren A, Talbot, Juliette C, Thompson, R Loch, Macdonald
Publikováno v:
Neurology and therapy.
Angiographic vasospasm (VSP), the narrowing of intracranial arteries, is a complication of aneurysmal subarachnoid hemorrhage (aSAH) and often results in delayed cerebral ischemia (DCI) and cerebral infarction. The objective of this systematic review
Autor:
François-Xavier Chalet, Pierre-Philippe Luyet, Cristina Rabasa, Cédric Vaillant, Paul Saskin, Ajay Ahuja, Leslie Citrome
Publikováno v:
SLEEP. 46:A155-A155
Introduction Patients with insomnia disorder have difficulty initiating or maintaining sleep and have impaired daytime functioning. Daridorexant is a dual orexin receptor antagonist approved for the treatment of insomnia. This analysis reports the nu
Publikováno v:
Médecine du Sommeil. 20:72